Atlas Venture

Venture Capital Est. 1980
Website →
USD 500M
Estimated FUM
Type
Venture Capital
HQ
Cambridge, MA, United States
Founded
1980
Focus
Life Sciences · Healthcare & Life Sciences

About

Atlas Venture is an early-stage venture capital firm that focuses on life science startups in the United States, in particular companies headquartered in Cambridge, Massachusetts. We are active investors that assist our companies position themselves for successful drug development and exits in all market environments. From its founding in 1980 until 2014, Atlas invested in both life sciences and technology, however since 2014, Atlas has focused exclusively on biotechnology.

Strategies

Venture Capital
Sources

Profile sources

  1. openvc.app — Life Sciences, Healthcare & Life Sciences

Recent venture activity

  • Mar 2026 · Reported 1 more venture fund to the SEC (14 in total) in its Form ADV filed 2026-03-31 · SEC Form ADV

Locations & investment markets

Capital and location details checked 2026-10-12.

Investment Criteria

Investment size
USD 5M - USD 30M

Reported investment size. Actual commitments may vary by stage, ownership and follow-on participation.

Investment Stages
Stages
Seed Series A Series B
Investment Geographies
Primary Markets
United States
Coverage
Country-focused
Regions
North America

Coverage is a guide only.

Location

Headquarters
Cambridge, MA, United States
More investors with offices in Boston
Office Presence
1 country
United States
1 known office
Cambridge, MA, United States (HQ)

Deals & Activity

Deals, last 12 months
0
None led
Deals, last 36 months
1
None led
Exits, last 36 months
0
0 on record
Most active, last 12 months
–

Recent deals

Rounds, buyouts and stakes from public sources · How this is counted
Tracked deals
9
Most common deal types
Unknown (8) Series B (1)
Deals by domain
Healthcare 1

Other recorded investments

Generationbio
2026
Akerotx
2025 - Healthcare
Dayonebio
2021
Dyne Tx
2020
Be Biopharma
Antaresrx
Accenttx
AAVantgarde Bio

Similar investors

5AM Ventures
5AM Ventures is a leading venture capital firm headquartered in San Francisco and focused on investments into early-stage life science companies. We invest in the biopharmaceutical, drug delivery technology and research instrument sectors. We support companies that are working to solve important healthcare needs via cutting-edge breakthroughs in medicine and science. 5AM works closely with our portfolio companies. Going beyond passive board roles, ours is unusually hands-on when starting companies, assuming short-term operating roles and proactively providing guidance throughout a portfolio company's life. 5AM Ventures, through our 4:59 initiative, also discovers, incubates and funds breakthrough science. We partner alongside academics and entrepreneurs - often serving as an extension of the operating team to establish proof-of-concept data that will enable a Series A Financing.
Tamarisc Ventures
Tamarisc Ventures is an early stage micro venture capital firm that invests in businesses at the intersection of technology and real estate.
NextView Ventures
NextView Ventures is a seed-stage venture firm headquartered in Boston. Nextview invests in technology driven companies redesigning what we call the Everyday Economy, which encompasses a wind range of startups primarily (but not only) focused on serving consumers, including in food, housing, apparel, transport, health, work, money and entertainment. We invest at the pre-seed and seed stage and usually invest before meaningful traction. Nextview was founded in 2010 by Dave Beisel (previously Venrock), Rob Go (Spark Capital) and Lee Hower (Judith Capital). Nextview Ventures raised its first $21m fund in 2012, a $40m fund in 2014 and a $50m fund in 2017.
Elephant Partners
Elephant Partners is a Boston-headquartered venture capital firm focused on the enterprise software, consumer internet and mobile markets. Elephant was founded in 2015 by Jeremiah Daly and Andy Hunt, who previously worked for Highland Capital Partners. Andy Hunt is also the co-founder of Warby Parker
Double Point Ventures
Double Point Ventures is a venture capital firm investing in healthcare companies across therapeutics, diagnostics, devices, and digital health.
Boston Seed
Boston Seed Capital is a venture firm investing at pre-seed and seed in technology companies across consumer, B2B SaaS, and infrastructure.

Other Venture Capital Firms in Boston

#1 General Catalyst
General Catalyst combines seed- and growth-focused VC funds with company creation and business buyouts, alongside tailored founder-capital solutions.
#2 Bessemer Venture Partners
Bessemer Venture Partners is the oldest venture capital firm in the United States, and invests in enterprise, consumer and healthcare technology startups around the world. Bessemer invests from seed stage to growth, and across the technology and services stack. With a history that includes early investments in Yelp, LinkedIn and Skype, Bessemer has earned a reputation for spotting fledgling stars in the notably hard to predict world of consumer tech.
#3 GV
GV is an independent venture capital firm launched as Google Ventures in 2009, with Alphabet as its sole limited partner. It invests from seed to growth in technology and life sciences and provides operating-partner support to founding teams.
#4 Spark Capital
Spark Capital is a US venture capital firm that partners with visionary entrepreneurs who are driven to move people with the products and experiences they create. We invest in companies at all stages of their life cycle, and have invested in some of the most successful global startups including Twitter, Tumblr, Oculus, Cruise and Slack. Spark Capital has raised seven funds since its founding in 2005, including its two most recent funds, a $400 million early-stage venture fund and a $600 million venture growth fund. Spark Capital primarily focuses on technology startups in the media, entertainment, and mobile sectors, and frequently co-invests with Union Square Ventures.
#5 Bain Capital Ventures
Bain Capital Ventures is a venture capital fund focused on high-growth enterprise software opportunities, including SaaS, data services, marketing-tech, fin-tech, healthcare and software. We partner with great B2B founders and accelerate their market vision. Our investments span $1 million seed capital through to $100m growth equity cheques. We draw on a global network of experience, and the full resources of Bain Capital, one of the world's leading alternative asset firms with more than $60 billion under management across a variety of investment strategies. Our focus areas currently include business applications (DocuSign, SendGrid, Gainsight), infrastructure and security (Redis Labs, Rubrik, Armis), financial technology (Acorns, IEX), healthcare IT (AbleTo, ABILITY Network), and consumer (Rent the Runway, Jet). We also have emerging practices in autonomy/mobility (Ike, Lime) and cryptocurrency (DCG, Compound Labs). Bain Capital Ventures invests globally, although the majority of our investments are in the United States
#6 Matrix Partners
Matrix Partners is a venture capital firm focused on early stage technology companies building B2B, infrastructure and consumer technology. We have been investing since 1977 and have invested in some of the most iconic technology companies. We invest globally, are headquartered in California, and have offices in Boston, Mumbai (Matrix Partners India) and China (Matrix Partners China). Matrix Partners was founded in 1977 by Paul Ferri and Warren Hellman.